中國廣核(003816.SZ):董事長張善明辭任
格隆匯3月3日丨中國廣核(003816.SZ)公佈,公司董事會於2020年3月3日收到張善明的書面辭職報告,張善明因工作調整向董事會請求辭去公司董事長、非執行董事、董事會提名委員會委員及董事會核安全委員會主任職務。
根據法律、法規、其他規範性文件和《中國廣核電力股份有限公司章程》規定,張善明的辭任自其辭職報告送達董事會時生效。自2020年3月3日後,張善明將不再擔任公司任何職務。
根據《中華人民共和國公司法》及《公司章程》,公司全體董事共同推舉執行董事高立剛代為履行董事長職務,代行職務期限自推舉之日起至公司選舉產生新任董事長之日止。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.